Casa
scp 666 1/2 j

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
CB2R agonists in the clinics for treating inflammatory diseases
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Enhancing the Endocannabinoid System in ME/CFS, Fibromyalgia and Long COVID: the Beta-Caryophyllene Option - Health Rising
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Full article: At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
The endocannabinoid system and its therapeutic exploitation
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Estrogen actions in the nervous system
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Biomedicines, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Biomedicines, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)